Full text is available at the source.
Abstract
A low-cost, robust CRISPR-based diagnostic platform can detect HIV RNA with sensitivity down to single-digit aM in ex vivo samples.
- Around 60% of people with HIV remain undiagnosed in resource-limited regions due to inadequate detection methods.
- The developed platform combines rolling circle amplification with a ratiometric CRISPR approach for enhanced sensitivity.
- The method utilizes phi29 DNA polymerase's unique activities to detect long HIV RNA without prior fragmentation.
- Detection involves converting supercoiled plasmid reporters to relaxed forms, allowing quantification of target concentration.
- An all-in-one smartphone-based minigel electrophoresis device enables equipment-free testing for HIV viral load.
Simplified